Professor Matthew Walters

  • Professor of Clinical Pharmacology (Institute of Cardiovascular and Medical Sciences)
  • Associate (School of Medicine)

Research interests

I am a CSO Clinician Scientist and Senior Lecturer within the division of Cardiovascular and Medical Sciences. My research interests involve the evaluation and treatment of disordered cerebral perfusion, and I run an active research programme in this area with 5 higher degree students currently under my supervision. Other research themes include the epidemiology of stroke disease, and outcome assessment after stroke.

Current projects include:

  • Studies of the relationship between carotid plaque composition and biological behaviour using magnetic resonance imaging and transcranial Doppler ultrasound.
  • Evaluation of reversibility of impaired cerebrovascular nitric oxide bioavailability in patients with diabetes.
  • Examination of the effect of xanthine oxidase inhibition on the cerebral vasculature.
  • A comprehensive evaluation of the impact of cerebrovascular disease in Scotland using the database of the Information and Statistics Division of the Scottish Executive.
  • Evaluation of the potential impact of video-based outcome assessment (using the modified Rankin score) in clinical trials of novel stroke therapies.

Key collaborators in these projects include Professor Henry Dargie, Dr Graeme Houston, Professor Peter Langhorne, Professor Simon Capewell, Professor John McMurray and Dr Kate McIntyre.

My work is supported by sources which include the Chief Scientist Office, Chest Heart and Stroke Scotland, the Translational Medicine Research Collaboration. Income from competitive sources was approximately £600,000 in 2006-2007.

In addition to non-commercial studies I am local Principal Investigator for a number of multicentre clinical trials. Our centre currently leads the UK in recruitment for the ECASS 3 trial of alteplase in acute ischaemic stroke. 

Research:

Clinical Trials:

Member:

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • Non invasive brain stimulation in stroke patients
    Scottish Executive Health Department
    2014 - 2017
     
  • GU Clinical Pharmacology Development Fund
    NHS Greater Glasgow and CLyde
    2014 - 2015
     
  • Xanthine oxidase inhibition for improvement of Long-term Outcomes following ischaemic stroke and transient ischaemic attack (XILO-FIST)
    Stroke Association
    2014 - 2019
     
  • Funding for Glasgow Evidence-based Medicine Society (GEMS) to organize research-orientated events
    National Student Association of Medical Research
    2013 - 2014
     
  • The INSPIRE programme
    Academy of Medical Sciences
    2013 - 2015
     
  • Robotic Therapy Early After Stroke Events (RTEASE).
    Chest, Heart & Stroke, Scotland
    2012 - 2015
     
  • EpiPGX: Epilepsy Pharmacogenomics - delivering biomarkers for clinical use
    European Commission
    2011 - 2015
     
  • Development of an efficient, robust MS-based platform for early detection of acute kidney injury
    Medical Research Council
    2011 - 2014
     
  • INTERSTROKE Importance of conventional and emerging risk factors for stroke in different regions of the world and in different ethnic groups: A case-control study
    Stroke Association
    2011 - 2013
     
  • Allopurinol and Cerebral Ischaemia; Developing a Model for a Future Clinical Trial
    NHS Greater Glasgow and Clyde
    2011 - 2013
     
  • Scottish Clinical Pharmacology and Pathology Programme (SCP3)
    MRC
    2011 - 2016
     
  • Scottish Hyperacute stroke Activity Register and Evaluation: SHARE
    Chest, Heart & Stroke, Scotland
    2009 - 2011
     
  • The effect of allopurinol on carotid intima-media thickness and markers of endothelial function in patients with recent stroke - a pilot study
    The Stroke Association
    2009 - 2012
     
  • The Impact of Intraventricular Haemorrhage on Functional Outcomes and Economic Cost of Stroke.
    The Stroke Association
    2009 - 2010
     
  • Central adjudication of modified Rankin scale disability assessments in acute stroke trials
    Scottish Executive Health Department
    2009 - 2010
     
  • 3 Tesla Cardiac Magnetic Resonance Imaging Facility at the BHF Glasgow Cardiovascular Research Centre
    British Heart Foundation
    2008 - 2009
     
  • Stroke in Scotland 1986-2004:epidemiology and impact on population and health care
    Scottish Executive Health Department
    2007 - 2009
     
  • Cerebrovascular nitric oxide bioavailability in type II diabetes
    Scottish Executive Health Department
    2005 - 2008
     

Publications

List by: Type | Date

Jump to: 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999
Number of items: 116.

2015

Lewsey, J. et al. (2015) Temporal trends and risk factors for readmission for infections, gastrointestinal and immobility complications after an incident hospitalisation for stroke in Scotland between 1997 and 2005. BMC Neurology, 15(3). (doi:10.1186/s12883-014-0257-1)

2014

Beattie, C. J., Fulton, R. L., Higgins, P., Padmanabhan, S., McCallum, L., Walters, M. R., Dominiczak, A. F., Touyz, R. M., and Dawson, J. (2014) Allopurinol initiation and change in blood pressure in older adults with hypertension. Hypertension, 64(5). pp. 1102-1107. (doi:10.1161/HYPERTENSIONAHA.114.03953)

Dunn, W. G., and Walters, M. R. (2014) A randomised crossover trial of the acute effects of a deep-fried Mars bar or porridge on the cerebral vasculature. Scottish Medical Journal, 59(4). pp. 182-187. (doi:10.1177/0036933014552359)

Broomfield, N. M., Quinn, T., Abdul-Rahim, A. H., Walters, M. R., and Evans, J. J. (2014) Depression and anxiety symptoms post-stroke/TIA: prevalence and associations in cross-sectional data from a regional stroke registry. BMC Neurology, 14. p. 198. (doi:10.1186/s12883-014-0198-8)

Kilarski, L. L. et al. (2014) Meta-analysis in more than 17,900 cases of ischemic stroke reveals a novel association at 12q24.12. Neurology, 83(8). pp. 678-685. (doi:10.1212/WNL.0000000000000707)

Higgins, P., Walters, M. R., Murray, H. M., McArthur, K., McConnachie, A., Lees, K. R., and Dawson, J. (2014) Allopurinol reduces brachial and central blood pressure, and carotid intima-media thickness progression after ischaemic stroke and transient ischaemic attack: a randomised controlled trial. Heart, 100(14). pp. 1085-1092. (doi:10.1136/heartjnl-2014-305683)

Traylor, M. et al. (2014) A novel MMP12 locus is associated with large artery atherosclerotic stroke using a genome-wide age-at-onset informed approach. PLoS Genetics, 10(7). e1004469. (doi:10.1371/journal.pgen.1004469)

Broomfield, N. M., Scoular, A., Welsh, P., Walters, M., and Evans, J. J. (2014) Poststroke anxiety is prevalent at the population level, especially among socially deprived and younger age community stroke survivors. International Journal of Stroke. (doi:10.1111/ijs.12109) (Early Online Publication)

Cowey, E., Smith, L. N., Stott, D. J., McAlpine, C. H., Mead, G. E., Barber, M., and Walters, M. (2014) Impact of a clinical pathway on end-of-life care following stroke: a mixed methods study. Palliative Medicine. (doi:10.1177/0269216314551378) (Early Online Publication)

Kepli, W. M., Fulton, R. L., Walters, M., Ali, M., Bath, P. M., and Dawson, J. (2014) Antiplatelet therapy following ischemic stroke - continue or change pre-existing therapy? In: International Stroke Conference 2014, San Diego, CA, USA, 12-14 Feb 2014, A135.

MacDonald, T. M. et al. (2014) Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia. BMJ Open, 4(7). e005354. (doi:10.1136/bmjopen-2014-005354)

McCallum, L. et al. (2014) Response to effect of serum chloride on mortality in hypertensive patients. Hypertension, 63(3). e15-e15. (doi:10.1161/HYPERTENSIONAHA.113.02926)

Williamson, C. et al. (2014) Family history of premature cardiovascular disease: blood pressure control and long-term mortality outcomes in hypertensive patients. European Heart Journal, 35(9). pp. 563-570. (doi:10.1093/eurheartj/eht539)

2013

McCallum, L. et al. (2013) Serum chloride is an independent predictor of mortality in hypertensive patients. Hypertension, 62(5). pp. 836-843. (doi:10.1161/HYPERTENSIONAHA.113.01793)

Aubini è re-Robb, L. et al. (2013) Blood pressure response to patterns of weather fluctuations and effect on mortality. Hypertension, 62(1). pp. 190-196. (doi:10.1161/HYPERTENSIONAHA.111.00686)

Morgan, T.C. et al. (2013) The modified graeb score: an enhanced tool for intraventricular hemorrhage measurement and prediction of functional outcome. Stroke, 44(3). pp. 635-641. (doi:10.1161/STROKEAHA.112.670653)

Bottle, A., Mozid, A., Grocott, H.P., Walters, M.R., Lees, K.R., Aylin, P., and Sanders, R.D. (2013) Preoperative risk factors in 10 418 patients with prior myocardial infarction and 5241 patients with prior unstable angina undergoing elective coronary artery bypass graft surgery. British Journal of Anaesthesia, 111(3). pp. 417-423. (doi:10.1093/bja/aet107)

Dawson, J. et al. (2013) Acetaminophen use and change in blood pressure in a hypertensive population. Journal of Hypertension, 31(7). pp. 1485-1490. (doi:10.1097/HJH.0b013e328360f6f8)

Dawson, J. et al. (2013) Serum uric acid level, longitudinal blood pressure, renal function, and long-term mortality in treated hypertensive patients. Hypertension, 62(1). pp. 105-111. (doi:10.1161/HYPERTENSIONAHA.113.00859)

Hastie, C. et al. (2013) Long-term and ultra-long term blood pressure variability during follow–up and mortality in 14522 patients with hypertension. Hypertension, 62(4). pp. 698-705. (doi:10.1161/HYPERTENSIONAHA.113.01343)

Kaste, M., Murayama, S., Ford, G.A., Dippel, D.W.J., Walters, M.R., and Tatlisumak, T. (2013) Safety, tolerability and pharmacokinetics of MCI-186 in patients with acute ischemic stroke: new formulation and dosing regimen. Cerebrovascular Diseases, 36(3). pp. 196-204. (doi:10.1159/000353680)

McArthur, K.S., Johnson, P.C.D., Quinn, T., Higgins, P., Langhorne, P., Walters, M.R., Weir, C.J., Dawson, J., and Lees, K.R. (2013) Improving the efficiency of stroke trials: feasibility and efficacy of group adjudication of functional end points. Stroke, 14(12). pp. 3422-3428. (doi:10.1161/STROKEAHA.113.002266)

2012

Traylor, M. et al. (2012) Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE Collaboration): a meta-analysis of genome-wide association studies. Lancet Neurology, 11(11). pp. 951-962. (doi:10.1016/S1474-4422(12)70234-X)

Paul, L. et al. (2012) Hematocrit predicts long-term mortality in a nonlinear and sex-specific manner in hypertensive adults. Hypertension, 60(3). pp. 631-638. (doi:10.1161/HYPERTENSIONAHA.112.191510)

Dawson, J., Quinn, T., Lees, K.R., and Walters, M.R. (2012) Microembolic signals and aspirin resistance in patients with carotid stenosis. Cardiovascular Therapeutics, 30(4). pp. 234-239. (doi:10.1111/j.1755-5922.2010.00259.x)

Higgins, P., Dawson, J., Lees, K.R., McArthur, K., Quinn, T.J., and Walters, M.R. (2012) Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis. Cardiovascular Therapeutics, 30(4). pp. 217-226. (doi:10.1111/j.1755-5922.2011.00277.x)

Bellenguez, C. et al. (2012) Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nature Genetics, 44(3). pp. 328-333. (doi:10.1038/ng.1081)

Dawson, J., Walters, M., Delles, C., Mischak, H., and Mullen, W. (2012) Urinary proteomics to support diagnosis of stroke. PLoS ONE, 7(5). e35879. (doi:10.1371/journal.pone.0035879)

2011

Quinn, T.J., Dawson, J., and Walters, M.R. (2011) Sugar and stroke: cerebrovascular disease and blood glucose control. Cardiovascular Therapeutics, 29(6). e31-e42. (doi:10.1111/j.1755-5922.2010.00166.x)

Yeap, P., Tziotzios, C., McMillan, N., and Walters, M. (2011) A small left pupil and a headache. Clinical Medicine, 11(4). pp. 402-404.

Macpherson, K.J. et al. (2011) Trends in incidence and in short term survival following a subarachnoid haemorrhage in Scotland, 1986 - 2005: a retrospective cohort study. BMC Neurology, 11(1). p. 38. (doi:10.1186/1471-2377-11-38)

Cameron, A., Dawson, J., Quinn, T.J., Walters, M.R., McInnes, G.T., Morrison, D., Sloan, W., and Lees, K.R. (2011) Long-term outcome following attendance at a transient ischemic attack clinic. International Journal of Stroke, 6(4). pp. 306-311. (doi:10.1111/j.1747-4949.2011.00591.x)

Higgins, P., Dawson, J., and Walters, M. (2011) Nanomedicine: Nanotubes reduce stroke damage. Nature Nanotechnology, 6(6). pp. 83-84. (doi:10.1038/nnano.2011.5)

Kerr, G.D., Higgins, P., Walters, M., Ghosh, S.K., Wright, F., Langhorne, P., and Stott, D.J. (2011) Socioeconomic status and transient ischaemic attack / stroke: a prospective observational study. Cerebrovascular Diseases, 31(2). pp. 130-137. (doi:10.1159/000321732)

McArthur, K.S., Quinn, T.J., Dawson, J., and Walters, M.R. (2011) Diagnosis and management of transient ischaemic attack and ischaemic stroke in the acute phase. British Medical Journal, 342. d1938. (doi:10.1136/bmj.d1938)

Nunn, K.P., Bridgett, M.R., Walters, M.R., and Walker, I. (2011) All I want for coagulation. Scottish Medical Journal, 56(4). pp. 183-187. (doi:10.1258/smj.2011.011154)

Tziotzios, C., and Walters, M. (2011) Keep your eyes open: an unusual case of ptosis. QJM, 104(3). pp. 257-258. (doi:10.1093/qjmed/hcq093)

Tziotzios, C., Walters, M., and Biesecker, L.G. (2011) More than just a big thumb. QJM, 104(11). pp. 989-991. (doi:10.1093/qjmed/hcq226)

2010

Quinn, T.J., Dawson, J., and Walters, M. (2010) Equality of access to “fast-track” stroke services in an older, socio-economically deprived Scottish population. Scottish Medical Journal, 55(3). pp. 18-21.

Bayes, H. K., Oyeniran, O., Shepherd, M., and Walters, M. (2010) Clinical Audit: Management of Acute Severe Asthma in West Glasgow. Scottish Medical Journal, 55(1). pp. 6-9. (doi:10.1258/rsmsmj.55.1.6)

Dawson, J., Quinn, T.J., Rafferty, M., Higgins, P., Ray, G., Lees, K.R., and Walters, M.R. (2010) Aspirin resistance and compliance with therapy. Cardiovascular Therapeutics, 29(5). pp. 301-307. (doi:10.1111/j.1755-5922.2010.00188.x)

Langhorne, P. et al. (2010) Estimating the impact of stroke unit care in a whole population: an epidemiological study using routine data. Journal of Neurology, Neurosurgery and Psychiatry, 81(2). pp. 1301-1305. (doi:10.1136/jnnp.2009.195131)

Lewsey, J. et al. (2010) Temporal trends in hospitalisation for stroke recurrence following incident hospitalisation for stroke in Scotland. BMC Medicine, 8. p. 23. (doi:10.1186/1741-7015-8-23)

McArthur, K., Dawson, J., and Walters, M. (2010) What is it with the weather and stroke? Expert Review of Neurotherapeutics, 10(2). pp. 243-249. (doi:10.1586/ERN.09.154)

Rafferty, M., Walters, M.R., and Dawson, J. (2010) Anti-Platelet Therapy and Aspirin Resistance - Clinically and Chemically Relevant? Current Medicinal Chemistry, 17(36). pp. 4578-4586. (doi:10.2174/092986710794182962)

2009

Dawson, J., Quinn, T.J., Harrow, C., Lees, K.R., and Walters, M. (2009) The effect of allopurinol on the cerebral vasculature of patients with subcortical stroke; a randomized trial. British Journal of Clinical Pharmacology, 68(5). pp. 662-668. (doi:10.1111/j.1365-2125.2009.03497.x)

Lewsey, J. et al. (2009) Age- and sex-specific trends in fatal incidence and hospitalized incidence of stroke in Scotland, 1986 to 2005. Circulation: Cardiovascular Quality and Outcomes, 2(5). pp. 475-483. (doi:10.1161/CIRCOUTCOMES.108.825968)

Quinn, T.J., Dawson, J., Walters, M., and Lees, K. (2009) Functional outcome measures in contemporary stroke trials. International Journal of Stroke, 4(3). pp. 200-205. (doi:10.1111/j.1747-4949.2009.00271.x)

Quinn, T.J., Dawson, J., Walters, M., and Lees, K.R. (2009) Functional outcome measures in contemporary stroke trials. International Journal of Stroke, 4(3). pp. 200-205. (doi:10.1111/j.1747-4949.2009.00271.x)

Lewsey, J.D. et al. (2009) Sex differences in incidence, mortality, and survival in individuals with stroke in Scotland, 1986 to 2005. Stroke, 40(4). pp. 1038-1043. (doi:10.1161/STROKEAHA.108.542787)

Dawson, J., Lees, K., Weir, C., Weir, C., Quinn, T., Ali, M., Hennerici, M., and Walters, M. (2009) Baseline Serum Urate and 90-Day Functional Outcomes following Acute Ischemic Stroke. Cerebrovascular Diseases, 28(2). pp. 202-203.

Dawson, J., Quinn, T., and Walters, M. (2009) Under the weather with stroke; more data emerge. International Journal of Stroke, 4(1). pp. 19-20.

Dawson, J., Lamb, K.E., Quinn, T.J., Lees, K.R., Horvers, M., Verrijth, M.J., and Walters, M. (2009) A recognition tool for transient ischaemic attack. QJM: An International Journal of Medicine, 102(1). pp. 43-49. (doi:10.1093/qjmed/hcn139)

Dawson, J., Quinn, T.J., Harrow, C., Lees, K.R., Weir, C., Cleland, S., and Walters, M. (2009) Allopurinol and nitric oxide activity in the cerebral circulation of those with diabetes. Diabetes Care, 32(1). pp. 135-137. (doi:10.2337/dc08-1179)

Quinn, T.J., Cameron, A., Dawson, J., Lees, K.R., and Walters, M.R. (2009) ABCD2 scores and prediction of noncerebrovascular diagnoses in an outpatient population: a case-control study. Stroke, 40(3). pp. 749-753. (doi:10.1161/STROKEAHA.108.530444)

Quinn, T.J., Cameron, A.D., Dawson, J., Walters, M., and Lees, K.R. (2009) A prospective study using the ABCD2 score in screening for minor stroke or transient ischaemic attack in referrals to a fast track clinic response. Stroke, 40(6). e468-e468. (doi:10.1161/STROKEAHA.109.551077)

Quinn, T.J., Dawson, J., Walters, M., and Lees, K.R. (2009) Exploring the reliability of the modified Rankin Scale. Stroke, 40(3). pp. 762-766. (doi:10.1161/STROKEAHA.108.522516)

Quinn, T.J., Dawson, J., Walters, M., and Lees, K.R. (2009) Reliability of the modified Rankin Scale: a systematic review. Stroke, 40(10). pp. 3393-3395. (doi:10.1161/STROKEAHA.109.557256)

Stewart, L., McInnes, G.T., Murray, L., Sloan, B., Walters, M., Morton, R., Padmanabhan, S., Reid, J.L., and Morrison, D.S. (2009) Risks of socioeconomic deprivation on mortality in hypertensive patients. Journal of Hypertension, 27(4). pp. 730-735. (doi:10.1097/HJH.0b013e328324ed58)

2008

Muir, S.W., Harrow, C., Dawson, J., Lees, K.R., Weir, C.J., Sattar, N., and Walters, M.R. (2008) Allopurinol use yields potentially beneficial effects on inflammatory indices in those with recent ischemic stroke: a randomized, double-blind, placebo-controlled trial. Stroke, 39(12). pp. 3303-3307. (doi:10.1161/STROKEAHA.108.519793)

Quinn, T.J., Dawson, J., Lees, J.S., Chang, T.P., Walters, M.R., and Lees, K.R. (2008) Time spent at home poststroke: “home-time” a meaningful and robust outcome measure for stroke trials. Stroke, 39(1). pp. 231-233. (doi:10.1161/STROKEAHA.107.493320)

Ahmad, F., Quinn, T., Dawson, J., and Walters, M. (2008) A link between lunar phase and medically unexplained stroke symptoms: An unearthly influence? Journal of Psychosomatic Research, 65(2). pp. 131-133. (doi:10.1016/j.jpsychores.2008.05.011 )

Dawson, J., Quinn, T.J., Lees, K.R., and Walters, M. (2008) The continued yin and yang of uric acid. Stroke, 39(1). e9-e9. (doi:10.1161/STROKEAHA.107.502245 )

Dawson, J., Quinn, T.J., and Walters, M. (2008) Uric acid: neuroprotective or neurotoxic? [reply]. Stroke, 39(5). e89-e89. (doi:10.1161/STROKEAHA.108.515635 )

Dawson, J., Weir, C., Wright, F., Bryden, C., Aslanyan, S., Lees, K., Bird, W., and Walters, M. (2008) Associations between meteorological variables and acute stroke hospital admissions in the west of Scotland. Acta Neurologica Scandinavica, 117(2). pp. 85-89. (doi:10.1111/j.1600-0404.2007.00916.x )

Lees, K.R. et al. (2008) Thrombolytic therapy for acute stroke in the United Kingdom: experience from the safe implementation of thrombolysis in stroke (SITS) register. QJM: An International Journal of Medicine, 101(11). pp. 863-869. (doi:10.1093/qjmed/hcn102)

Mackinnon, B., Padmanabhan, S., Murray, L., Sloan, W., Meredith, P., Reid, J., Walters, M., Jardine, A., Simpson, K., and McInnes, G. (2008) Is end stage renal disease a common outcome among patients attending a hypertension clinic? Journal of Hypertension, 26. S112-S112.

McCormick, M.T., Muir, K.W., Gray, C.S., and Walters, M.R. (2008) Management of hyperglycemia in acute stroke: how, when, and for whom? Stroke, 39(7). pp. 2177-2185. (doi:10.1161/STROKEAHA.107.496646)

McInnes, C., McAlpine, C., and Walters, M. (2008) Effect of gender on stroke management in Glasgow. Age and Ageing, 37(2). pp. 220-222.

Quinn, T.J., Dawson, J., and Walters, M. (2008) Dr John Rankin; His life, legacy and the 50th anniversary of the Rankin stroke scale. Scottish Medical Journal, 53(1). pp. 44-47.

Quinn, T.J., Dawson, J., Walters, M., and Lees, K.R. (2008) Variability in modified rankin scoring across a large cohort of observers. Stroke, 39(11). pp. 2975-2979. (doi:10.1161/STROKEAHA.108.515262)

Quinn, T.J., Ray, G., Atula, S., Walters, M.R., Dawson, J., and Lees, K.R. (2008) Deriving modified rankin scores from medical records. Stroke, 39(12). pp. 3421-3423. (doi:10.1161/STROKEAHA.108.519306)

Shah, I.M., Walters, M., and McKillop, J.H. (2008) Acute medicine teaching in an undergraduate medical curriculum: a blended learning approach. Emergency Medicine Journal, 25(6). pp. 354-357. (doi:10.1136/emj.2007.053082)

2007

Weir, R. A.P., Oldroyd, K. G., and Walters, M. R. (2007) Myocardial infarction after oral Sumatriptan use in a woman with normal coronary arteries. American Journal of Medicine , 120(11). E7-E8. (doi:10.1016/j.amjmed.2006.03.047)

Quinn, T.J., Dawson, J., Walters, M.R., and Lees, K.R. (2007) Reliability of the modified rankin scale. Stroke, 38(11). e144. (doi:10.1161/STROKEAHA.107.490110)

Alem, M., Cleland, S., Nazir, F., Small, M., and Walters, M. (2007) Inhibition of nitric oxide increases arterial stiffness in Type 2 diabetic patients. Diabetic Medicine, 24(7). pp. 803-804.

Dawson, J., Lamb, K., Horvers, M., Verrijth, M., Lees, K., and Walters, M. (2007) A recognition tool for evaluation of suspected transient ischemic attack. Stroke, 38(2). p. 487.

Dawson, J. et al. (2007) Serum uric acid and stroke in hypertension: Influence of gender. Journal of Hypertension, 25. S277-S278.

Dawson, J., Nalci, Y., McInnes, G., Murray, L., Morton, R., Radziwonik, S., Sloan, W., and Walters, M. (2007) Serum uric acid and stroke mortality in patients with hypertension. Journal of Human Hypertension, 21(10). pp. 843-844.

Dawson, J., Lees, J.S., Chang, T.P., Walters, M.R., Ali, M., Davis, S.M., Diener, H.C., and Lees, K.R. (2007) Association between disability measures and healthcare costs after initial treatment for acute stroke. Stroke, 38(6). pp. 1893-1898. (doi:10.1161/STROKEAHA.106.472381)

Dawson, J., Quinn, T.J., and Walters, M. (2007) Uric acid reduction: A new paradigm in the management of cardiovascular risk? Current Medicinal Chemistry, 14(17). pp. 1879-1886.

Finn, D., Dawson, J., Murray, L., Morton, R., Sloan, W., Walters, M., and McInnes, G. (2007) New-onset diabetes in hypertensive patients: an evaluation of the association with drug therapy and cardiovascular mortality. Journal of Human Hypertension, 21(10). pp. 842-843.

Quinn, T.J., Lees, K.R., Hardemark, H.G., Dawson, J., and Walters, M.R. (2007) Initial experience of a digital training resource for modified Rankin scale assessment in clinical trials. Stroke, 38(8). pp. 2257-2261. (doi:10.1161/STROKEAHA.106.480723)

Walker, T., McMahon, S., and Walters, M. (2007) Innovative orientation: a treasure hunt in Foundation Year one. Medical Education, 41(5). p. 514.

2006

Bain, C., Lees, K., Lumsden, M., and Walters, M. (2006) Sex hormones and cerebral hemodynamics - Author's reply. Climacteric, 9(1). p. 67.

Dawson, J., and Walters, M. (2006) New and emerging treatments for stroke. British Medical Bulletin, 77-78. pp. 87-102. (doi:10.1093/bmb/ldl011)

Dawson, J., and Walters, M. (2006) Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease? British Journal of Clinical Pharmacology, 62. pp. 633-644. (doi:10.1111/j.1365-2125.2006.02785.x)

Dawson, J., Walters, M., and Lees, K. (2006) 21st century stroke - A medical emergency. Scottish Medical Journal, 51(3). pp. 34-41.

Milia, P., Muir, S., Alem, M., Lees, K., and Walters, M. (2006) Comparison of the effect of diuretics on carotid blood flow in stroke patients. Journal of Cardiovascular Pharmacology, 47. pp. 446-449.

Nazir, F., Alem, M., Small, M., Connell, J., Lees, K., Walters, M., and Cleland, S. (2006) Blunted response to systemic nitric oxide synthase inhibition in the cerebral circulation of patients with Type 2 diabetes. Diabetic Medicine, 23. pp. 398-402. (doi:10.1111/j.1464-5491.2005.01815.x)

Newman, E.J., Rahman, F.S., Lees, K.R., Weir, C.J., and Walters, M. (2006) Elevated serum urate concentration independently predicts poor outcome following stroke in patients with diabetes. Diabetes: Metabolism Research and Reviews, 22(1). pp. 79-82.

Walters, M., Weir, C., and Lees, K. (2006) A randomised, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischaemic stroke patients. Cerebrovascular Diseases, 22. pp. 116-122. (doi:10.1159/000093239)

2005

Aslanyan, S., Weir, C., McInnes, G., Reid, J., Walters, M., and Lees, K. (2005) Statin administration prior to ischaemic stroke onset and survival: exploratory evidence from matched treatment-control study. European Journal of Neurology, 12. pp. 493-498.

Bain, C., Lees, K., Lumsden, M., and Walters, M. (2005) Effect of a gonadotropin releasing hormone analog on cerebral hemodynamics in premenopausal women. Climacteric, 8. pp. 193-197. (doi:10.1080/13697130500118068)

Dawson, J., and Walters, M. (2005) Development and validation of a stroke recognition tool. Lancet Neurology, 4(11). pp. 691-693.

Lees, K., and Walters, M. (2005) Acute stroke and diabetes. Cerebrovascular Diseases, 20(Suppl.). pp. 9-14. (doi:10.1159/000088232)

Walters, M., Kaste, M., Lees, K., Diener, H., Hommel, M., De Keyser, J., Steiner, H., and Versavel, M. (2005) The AMPA antagonist ZK 200775 in patients with acute ischaemic stroke: A double-blind, multicentre, placebo-controlled safety and tolerability study. Cerebrovascular Diseases, 20. pp. 304-309. (doi:10.1159/000087929)

Walters, M., Muir, K., Harbison, J., Lees, K., and Ford, G. (2005) Intravenous thrombolysis for acute ischaemic stroke: Preliminary experience with recombinant tissue plasminogen activator in the UK. Cerebrovascular Diseases, 20. pp. 438-442. (doi:10.1159/000088982)

Walters, M., Weir, C., Adams, F., and Lees, K. (2005) The prognostic significance of visible infarction on computed tomography following lacunar stroke: Results of a long-term follow-up study. Journal of Neuroimaging, 15. pp. 331-335. (doi:10.1177/1051228405279993)

2004

Alem, M., Nazir, F., Walters, M., Elliott, H., Lees, K., Connell, J., and Cleland, S. (2004) Arterial stiffness in type 2 diabetes: Altered pattern of response to systemic NOS inhibition. Journal of Hypertension, 22. S194-S195.

Bain, C., Walters, M., Lees, K., and Lumsden, M. (2004) The effect of HRT on cerebral haemodynamics and cerebral vasomotor reactivity in post-menopausal women. Human Reproduction, 19. pp. 2411-2414. (doi:10.1093/humrep/deh396)

Muir, S., Shah, I., Walters, M., and Lees, K. (2004) Perindopril improves cerebral vasomotor reactivity in patients with lacunar infarction. Stroke, 35(1). p. 303.

Nazir, F., Alem, M., Walters, M., Cleland, S., and Lees, K. (2004) Cerebral nitric oxide - Mediated vasodilatation is impaired in diabetics. Stroke, 35(1). p. 306.

Walters, M., Muir, S., Shah, I., and Lees, K. (2004) Effect of perindopril on cerebral vasomotor reactivity in patients with lacunar infarction. Stroke, 35. pp. 1899-1902. (doi:10.1161/01.STR.0000131748.12553.ed)

Weir, C., Muir, S., Walters, M., and Lees, K. (2004) Yin and Yang of uric acid in patients with stroke - Response. Stroke, 35(1). E11-E12.

2003

Dhanjal, T., Walters, M., and MacMillan, N. (2003) Claude's syndrome in association with posterior cerebral artery stenosis. Scottish Medical Journal, 48. pp. 91-92.

Shah, I., Walters, M., and McKillop, J. (2003) Interactive acute medicine. Medical Education, 37(11). pp. 1046-1047.

Walters, M., Shah, I., Van Acker, J., Carr, L., Weir, C., and Lees, K. (2003) Do transient ischaemic attacks attenuate severity of subsequent stroke? Stroke, 34(1). p. 320.

Weir, C., Muir, S., Walters, M., and Lees, K. (2003) Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke, 34. pp. 1951-1956. (doi:10.1161/01.STR.0000081983.34771.D2)

Weir, C., Sattar, N., Walters, M., and Lees, K. (2003) Low triglyceride, not low cholesterol concentration, independently predicts poor outcome following acute stroke. Cerebrovascular Diseases, 16. pp. 76-82. (doi:10.1159/000070119)

2002

Walters, M., Bradford, A., Fischer, J., and Lees, K. (2002) Early clinical experience with the novel NMDA receptor antagonist CNS 5161. British Journal of Clinical Pharmacology, 53. pp. 305-311.

2001

Walters, M., Bolster, A., Dyker, A., and Lees, K. (2001) Effect of perindopril on cerebral and renal perfusion in stroke patients with carotid disease. Stroke, 32. pp. 473-478.

2000

Walters, M., Dyker, A., and Lees, K. (2000) The effect of perindopril on cerebral and renal perfusion in stroke patients with carotid disease. Journal of Hypertension, 18. S53-S53.

Walters, M., and Reid, J. (2000) Vasopeptidase inhibition: cardiovascular therapy for the new millennium? Journal of Human Hypertension, 14(9). pp. 537-539.

1999

Walters, M., Bradford, A., and Lees, K. (1999) Early clinical experience with the novel NMDA antagonist CNS 5161. Stroke, 30(1). p. 264.

Walters, M., Foster, J., Cockburn, M., McMillan, N., and Lees, K. (1999) Imaging of acute ischaemic stroke by diffusion-weighted magnetic resonance at 1.0 tesla. Stroke, 30(1). p. 277.

This list was generated on Fri Feb 27 10:15:34 2015 GMT.
Number of items: 116.

Articles

Lewsey, J. et al. (2015) Temporal trends and risk factors for readmission for infections, gastrointestinal and immobility complications after an incident hospitalisation for stroke in Scotland between 1997 and 2005. BMC Neurology, 15(3). (doi:10.1186/s12883-014-0257-1)

Beattie, C. J., Fulton, R. L., Higgins, P., Padmanabhan, S., McCallum, L., Walters, M. R., Dominiczak, A. F., Touyz, R. M., and Dawson, J. (2014) Allopurinol initiation and change in blood pressure in older adults with hypertension. Hypertension, 64(5). pp. 1102-1107. (doi:10.1161/HYPERTENSIONAHA.114.03953)

Dunn, W. G., and Walters, M. R. (2014) A randomised crossover trial of the acute effects of a deep-fried Mars bar or porridge on the cerebral vasculature. Scottish Medical Journal, 59(4). pp. 182-187. (doi:10.1177/0036933014552359)

Broomfield, N. M., Quinn, T., Abdul-Rahim, A. H., Walters, M. R., and Evans, J. J. (2014) Depression and anxiety symptoms post-stroke/TIA: prevalence and associations in cross-sectional data from a regional stroke registry. BMC Neurology, 14. p. 198. (doi:10.1186/s12883-014-0198-8)

Kilarski, L. L. et al. (2014) Meta-analysis in more than 17,900 cases of ischemic stroke reveals a novel association at 12q24.12. Neurology, 83(8). pp. 678-685. (doi:10.1212/WNL.0000000000000707)

Higgins, P., Walters, M. R., Murray, H. M., McArthur, K., McConnachie, A., Lees, K. R., and Dawson, J. (2014) Allopurinol reduces brachial and central blood pressure, and carotid intima-media thickness progression after ischaemic stroke and transient ischaemic attack: a randomised controlled trial. Heart, 100(14). pp. 1085-1092. (doi:10.1136/heartjnl-2014-305683)

Traylor, M. et al. (2014) A novel MMP12 locus is associated with large artery atherosclerotic stroke using a genome-wide age-at-onset informed approach. PLoS Genetics, 10(7). e1004469. (doi:10.1371/journal.pgen.1004469)

Broomfield, N. M., Scoular, A., Welsh, P., Walters, M., and Evans, J. J. (2014) Poststroke anxiety is prevalent at the population level, especially among socially deprived and younger age community stroke survivors. International Journal of Stroke. (doi:10.1111/ijs.12109) (Early Online Publication)

Cowey, E., Smith, L. N., Stott, D. J., McAlpine, C. H., Mead, G. E., Barber, M., and Walters, M. (2014) Impact of a clinical pathway on end-of-life care following stroke: a mixed methods study. Palliative Medicine. (doi:10.1177/0269216314551378) (Early Online Publication)

MacDonald, T. M. et al. (2014) Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia. BMJ Open, 4(7). e005354. (doi:10.1136/bmjopen-2014-005354)

McCallum, L. et al. (2014) Response to effect of serum chloride on mortality in hypertensive patients. Hypertension, 63(3). e15-e15. (doi:10.1161/HYPERTENSIONAHA.113.02926)

Williamson, C. et al. (2014) Family history of premature cardiovascular disease: blood pressure control and long-term mortality outcomes in hypertensive patients. European Heart Journal, 35(9). pp. 563-570. (doi:10.1093/eurheartj/eht539)

McCallum, L. et al. (2013) Serum chloride is an independent predictor of mortality in hypertensive patients. Hypertension, 62(5). pp. 836-843. (doi:10.1161/HYPERTENSIONAHA.113.01793)

Aubini è re-Robb, L. et al. (2013) Blood pressure response to patterns of weather fluctuations and effect on mortality. Hypertension, 62(1). pp. 190-196. (doi:10.1161/HYPERTENSIONAHA.111.00686)

Morgan, T.C. et al. (2013) The modified graeb score: an enhanced tool for intraventricular hemorrhage measurement and prediction of functional outcome. Stroke, 44(3). pp. 635-641. (doi:10.1161/STROKEAHA.112.670653)

Bottle, A., Mozid, A., Grocott, H.P., Walters, M.R., Lees, K.R., Aylin, P., and Sanders, R.D. (2013) Preoperative risk factors in 10 418 patients with prior myocardial infarction and 5241 patients with prior unstable angina undergoing elective coronary artery bypass graft surgery. British Journal of Anaesthesia, 111(3). pp. 417-423. (doi:10.1093/bja/aet107)

Dawson, J. et al. (2013) Acetaminophen use and change in blood pressure in a hypertensive population. Journal of Hypertension, 31(7). pp. 1485-1490. (doi:10.1097/HJH.0b013e328360f6f8)

Dawson, J. et al. (2013) Serum uric acid level, longitudinal blood pressure, renal function, and long-term mortality in treated hypertensive patients. Hypertension, 62(1). pp. 105-111. (doi:10.1161/HYPERTENSIONAHA.113.00859)

Hastie, C. et al. (2013) Long-term and ultra-long term blood pressure variability during follow–up and mortality in 14522 patients with hypertension. Hypertension, 62(4). pp. 698-705. (doi:10.1161/HYPERTENSIONAHA.113.01343)

Kaste, M., Murayama, S., Ford, G.A., Dippel, D.W.J., Walters, M.R., and Tatlisumak, T. (2013) Safety, tolerability and pharmacokinetics of MCI-186 in patients with acute ischemic stroke: new formulation and dosing regimen. Cerebrovascular Diseases, 36(3). pp. 196-204. (doi:10.1159/000353680)

McArthur, K.S., Johnson, P.C.D., Quinn, T., Higgins, P., Langhorne, P., Walters, M.R., Weir, C.J., Dawson, J., and Lees, K.R. (2013) Improving the efficiency of stroke trials: feasibility and efficacy of group adjudication of functional end points. Stroke, 14(12). pp. 3422-3428. (doi:10.1161/STROKEAHA.113.002266)

Traylor, M. et al. (2012) Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE Collaboration): a meta-analysis of genome-wide association studies. Lancet Neurology, 11(11). pp. 951-962. (doi:10.1016/S1474-4422(12)70234-X)

Paul, L. et al. (2012) Hematocrit predicts long-term mortality in a nonlinear and sex-specific manner in hypertensive adults. Hypertension, 60(3). pp. 631-638. (doi:10.1161/HYPERTENSIONAHA.112.191510)

Dawson, J., Quinn, T., Lees, K.R., and Walters, M.R. (2012) Microembolic signals and aspirin resistance in patients with carotid stenosis. Cardiovascular Therapeutics, 30(4). pp. 234-239. (doi:10.1111/j.1755-5922.2010.00259.x)

Higgins, P., Dawson, J., Lees, K.R., McArthur, K., Quinn, T.J., and Walters, M.R. (2012) Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis. Cardiovascular Therapeutics, 30(4). pp. 217-226. (doi:10.1111/j.1755-5922.2011.00277.x)

Bellenguez, C. et al. (2012) Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nature Genetics, 44(3). pp. 328-333. (doi:10.1038/ng.1081)

Dawson, J., Walters, M., Delles, C., Mischak, H., and Mullen, W. (2012) Urinary proteomics to support diagnosis of stroke. PLoS ONE, 7(5). e35879. (doi:10.1371/journal.pone.0035879)

Quinn, T.J., Dawson, J., and Walters, M.R. (2011) Sugar and stroke: cerebrovascular disease and blood glucose control. Cardiovascular Therapeutics, 29(6). e31-e42. (doi:10.1111/j.1755-5922.2010.00166.x)

Yeap, P., Tziotzios, C., McMillan, N., and Walters, M. (2011) A small left pupil and a headache. Clinical Medicine, 11(4). pp. 402-404.

Macpherson, K.J. et al. (2011) Trends in incidence and in short term survival following a subarachnoid haemorrhage in Scotland, 1986 - 2005: a retrospective cohort study. BMC Neurology, 11(1). p. 38. (doi:10.1186/1471-2377-11-38)

Cameron, A., Dawson, J., Quinn, T.J., Walters, M.R., McInnes, G.T., Morrison, D., Sloan, W., and Lees, K.R. (2011) Long-term outcome following attendance at a transient ischemic attack clinic. International Journal of Stroke, 6(4). pp. 306-311. (doi:10.1111/j.1747-4949.2011.00591.x)

Higgins, P., Dawson, J., and Walters, M. (2011) Nanomedicine: Nanotubes reduce stroke damage. Nature Nanotechnology, 6(6). pp. 83-84. (doi:10.1038/nnano.2011.5)

Kerr, G.D., Higgins, P., Walters, M., Ghosh, S.K., Wright, F., Langhorne, P., and Stott, D.J. (2011) Socioeconomic status and transient ischaemic attack / stroke: a prospective observational study. Cerebrovascular Diseases, 31(2). pp. 130-137. (doi:10.1159/000321732)

McArthur, K.S., Quinn, T.J., Dawson, J., and Walters, M.R. (2011) Diagnosis and management of transient ischaemic attack and ischaemic stroke in the acute phase. British Medical Journal, 342. d1938. (doi:10.1136/bmj.d1938)

Nunn, K.P., Bridgett, M.R., Walters, M.R., and Walker, I. (2011) All I want for coagulation. Scottish Medical Journal, 56(4). pp. 183-187. (doi:10.1258/smj.2011.011154)

Tziotzios, C., and Walters, M. (2011) Keep your eyes open: an unusual case of ptosis. QJM, 104(3). pp. 257-258. (doi:10.1093/qjmed/hcq093)

Tziotzios, C., Walters, M., and Biesecker, L.G. (2011) More than just a big thumb. QJM, 104(11). pp. 989-991. (doi:10.1093/qjmed/hcq226)

Quinn, T.J., Dawson, J., and Walters, M. (2010) Equality of access to “fast-track” stroke services in an older, socio-economically deprived Scottish population. Scottish Medical Journal, 55(3). pp. 18-21.

Bayes, H. K., Oyeniran, O., Shepherd, M., and Walters, M. (2010) Clinical Audit: Management of Acute Severe Asthma in West Glasgow. Scottish Medical Journal, 55(1). pp. 6-9. (doi:10.1258/rsmsmj.55.1.6)

Dawson, J., Quinn, T.J., Rafferty, M., Higgins, P., Ray, G., Lees, K.R., and Walters, M.R. (2010) Aspirin resistance and compliance with therapy. Cardiovascular Therapeutics, 29(5). pp. 301-307. (doi:10.1111/j.1755-5922.2010.00188.x)

Langhorne, P. et al. (2010) Estimating the impact of stroke unit care in a whole population: an epidemiological study using routine data. Journal of Neurology, Neurosurgery and Psychiatry, 81(2). pp. 1301-1305. (doi:10.1136/jnnp.2009.195131)

Lewsey, J. et al. (2010) Temporal trends in hospitalisation for stroke recurrence following incident hospitalisation for stroke in Scotland. BMC Medicine, 8. p. 23. (doi:10.1186/1741-7015-8-23)

McArthur, K., Dawson, J., and Walters, M. (2010) What is it with the weather and stroke? Expert Review of Neurotherapeutics, 10(2). pp. 243-249. (doi:10.1586/ERN.09.154)

Rafferty, M., Walters, M.R., and Dawson, J. (2010) Anti-Platelet Therapy and Aspirin Resistance - Clinically and Chemically Relevant? Current Medicinal Chemistry, 17(36). pp. 4578-4586. (doi:10.2174/092986710794182962)

Dawson, J., Quinn, T.J., Harrow, C., Lees, K.R., and Walters, M. (2009) The effect of allopurinol on the cerebral vasculature of patients with subcortical stroke; a randomized trial. British Journal of Clinical Pharmacology, 68(5). pp. 662-668. (doi:10.1111/j.1365-2125.2009.03497.x)

Lewsey, J. et al. (2009) Age- and sex-specific trends in fatal incidence and hospitalized incidence of stroke in Scotland, 1986 to 2005. Circulation: Cardiovascular Quality and Outcomes, 2(5). pp. 475-483. (doi:10.1161/CIRCOUTCOMES.108.825968)

Quinn, T.J., Dawson, J., Walters, M., and Lees, K. (2009) Functional outcome measures in contemporary stroke trials. International Journal of Stroke, 4(3). pp. 200-205. (doi:10.1111/j.1747-4949.2009.00271.x)

Quinn, T.J., Dawson, J., Walters, M., and Lees, K.R. (2009) Functional outcome measures in contemporary stroke trials. International Journal of Stroke, 4(3). pp. 200-205. (doi:10.1111/j.1747-4949.2009.00271.x)

Lewsey, J.D. et al. (2009) Sex differences in incidence, mortality, and survival in individuals with stroke in Scotland, 1986 to 2005. Stroke, 40(4). pp. 1038-1043. (doi:10.1161/STROKEAHA.108.542787)

Dawson, J., Lees, K., Weir, C., Weir, C., Quinn, T., Ali, M., Hennerici, M., and Walters, M. (2009) Baseline Serum Urate and 90-Day Functional Outcomes following Acute Ischemic Stroke. Cerebrovascular Diseases, 28(2). pp. 202-203.

Dawson, J., Quinn, T., and Walters, M. (2009) Under the weather with stroke; more data emerge. International Journal of Stroke, 4(1). pp. 19-20.

Dawson, J., Lamb, K.E., Quinn, T.J., Lees, K.R., Horvers, M., Verrijth, M.J., and Walters, M. (2009) A recognition tool for transient ischaemic attack. QJM: An International Journal of Medicine, 102(1). pp. 43-49. (doi:10.1093/qjmed/hcn139)

Dawson, J., Quinn, T.J., Harrow, C., Lees, K.R., Weir, C., Cleland, S., and Walters, M. (2009) Allopurinol and nitric oxide activity in the cerebral circulation of those with diabetes. Diabetes Care, 32(1). pp. 135-137. (doi:10.2337/dc08-1179)

Quinn, T.J., Cameron, A., Dawson, J., Lees, K.R., and Walters, M.R. (2009) ABCD2 scores and prediction of noncerebrovascular diagnoses in an outpatient population: a case-control study. Stroke, 40(3). pp. 749-753. (doi:10.1161/STROKEAHA.108.530444)

Quinn, T.J., Cameron, A.D., Dawson, J., Walters, M., and Lees, K.R. (2009) A prospective study using the ABCD2 score in screening for minor stroke or transient ischaemic attack in referrals to a fast track clinic response. Stroke, 40(6). e468-e468. (doi:10.1161/STROKEAHA.109.551077)

Quinn, T.J., Dawson, J., Walters, M., and Lees, K.R. (2009) Exploring the reliability of the modified Rankin Scale. Stroke, 40(3). pp. 762-766. (doi:10.1161/STROKEAHA.108.522516)

Quinn, T.J., Dawson, J., Walters, M., and Lees, K.R. (2009) Reliability of the modified Rankin Scale: a systematic review. Stroke, 40(10). pp. 3393-3395. (doi:10.1161/STROKEAHA.109.557256)

Stewart, L., McInnes, G.T., Murray, L., Sloan, B., Walters, M., Morton, R., Padmanabhan, S., Reid, J.L., and Morrison, D.S. (2009) Risks of socioeconomic deprivation on mortality in hypertensive patients. Journal of Hypertension, 27(4). pp. 730-735. (doi:10.1097/HJH.0b013e328324ed58)

Muir, S.W., Harrow, C., Dawson, J., Lees, K.R., Weir, C.J., Sattar, N., and Walters, M.R. (2008) Allopurinol use yields potentially beneficial effects on inflammatory indices in those with recent ischemic stroke: a randomized, double-blind, placebo-controlled trial. Stroke, 39(12). pp. 3303-3307. (doi:10.1161/STROKEAHA.108.519793)

Quinn, T.J., Dawson, J., Lees, J.S., Chang, T.P., Walters, M.R., and Lees, K.R. (2008) Time spent at home poststroke: “home-time” a meaningful and robust outcome measure for stroke trials. Stroke, 39(1). pp. 231-233. (doi:10.1161/STROKEAHA.107.493320)

Ahmad, F., Quinn, T., Dawson, J., and Walters, M. (2008) A link between lunar phase and medically unexplained stroke symptoms: An unearthly influence? Journal of Psychosomatic Research, 65(2). pp. 131-133. (doi:10.1016/j.jpsychores.2008.05.011 )

Dawson, J., Quinn, T.J., Lees, K.R., and Walters, M. (2008) The continued yin and yang of uric acid. Stroke, 39(1). e9-e9. (doi:10.1161/STROKEAHA.107.502245 )

Dawson, J., Quinn, T.J., and Walters, M. (2008) Uric acid: neuroprotective or neurotoxic? [reply]. Stroke, 39(5). e89-e89. (doi:10.1161/STROKEAHA.108.515635 )

Dawson, J., Weir, C., Wright, F., Bryden, C., Aslanyan, S., Lees, K., Bird, W., and Walters, M. (2008) Associations between meteorological variables and acute stroke hospital admissions in the west of Scotland. Acta Neurologica Scandinavica, 117(2). pp. 85-89. (doi:10.1111/j.1600-0404.2007.00916.x )

Lees, K.R. et al. (2008) Thrombolytic therapy for acute stroke in the United Kingdom: experience from the safe implementation of thrombolysis in stroke (SITS) register. QJM: An International Journal of Medicine, 101(11). pp. 863-869. (doi:10.1093/qjmed/hcn102)

Mackinnon, B., Padmanabhan, S., Murray, L., Sloan, W., Meredith, P., Reid, J., Walters, M., Jardine, A., Simpson, K., and McInnes, G. (2008) Is end stage renal disease a common outcome among patients attending a hypertension clinic? Journal of Hypertension, 26. S112-S112.

McCormick, M.T., Muir, K.W., Gray, C.S., and Walters, M.R. (2008) Management of hyperglycemia in acute stroke: how, when, and for whom? Stroke, 39(7). pp. 2177-2185. (doi:10.1161/STROKEAHA.107.496646)

McInnes, C., McAlpine, C., and Walters, M. (2008) Effect of gender on stroke management in Glasgow. Age and Ageing, 37(2). pp. 220-222.

Quinn, T.J., Dawson, J., and Walters, M. (2008) Dr John Rankin; His life, legacy and the 50th anniversary of the Rankin stroke scale. Scottish Medical Journal, 53(1). pp. 44-47.

Quinn, T.J., Dawson, J., Walters, M., and Lees, K.R. (2008) Variability in modified rankin scoring across a large cohort of observers. Stroke, 39(11). pp. 2975-2979. (doi:10.1161/STROKEAHA.108.515262)

Quinn, T.J., Ray, G., Atula, S., Walters, M.R., Dawson, J., and Lees, K.R. (2008) Deriving modified rankin scores from medical records. Stroke, 39(12). pp. 3421-3423. (doi:10.1161/STROKEAHA.108.519306)

Shah, I.M., Walters, M., and McKillop, J.H. (2008) Acute medicine teaching in an undergraduate medical curriculum: a blended learning approach. Emergency Medicine Journal, 25(6). pp. 354-357. (doi:10.1136/emj.2007.053082)

Weir, R. A.P., Oldroyd, K. G., and Walters, M. R. (2007) Myocardial infarction after oral Sumatriptan use in a woman with normal coronary arteries. American Journal of Medicine , 120(11). E7-E8. (doi:10.1016/j.amjmed.2006.03.047)

Quinn, T.J., Dawson, J., Walters, M.R., and Lees, K.R. (2007) Reliability of the modified rankin scale. Stroke, 38(11). e144. (doi:10.1161/STROKEAHA.107.490110)

Alem, M., Cleland, S., Nazir, F., Small, M., and Walters, M. (2007) Inhibition of nitric oxide increases arterial stiffness in Type 2 diabetic patients. Diabetic Medicine, 24(7). pp. 803-804.

Dawson, J., Lamb, K., Horvers, M., Verrijth, M., Lees, K., and Walters, M. (2007) A recognition tool for evaluation of suspected transient ischemic attack. Stroke, 38(2). p. 487.

Dawson, J. et al. (2007) Serum uric acid and stroke in hypertension: Influence of gender. Journal of Hypertension, 25. S277-S278.

Dawson, J., Nalci, Y., McInnes, G., Murray, L., Morton, R., Radziwonik, S., Sloan, W., and Walters, M. (2007) Serum uric acid and stroke mortality in patients with hypertension. Journal of Human Hypertension, 21(10). pp. 843-844.

Dawson, J., Lees, J.S., Chang, T.P., Walters, M.R., Ali, M., Davis, S.M., Diener, H.C., and Lees, K.R. (2007) Association between disability measures and healthcare costs after initial treatment for acute stroke. Stroke, 38(6). pp. 1893-1898. (doi:10.1161/STROKEAHA.106.472381)

Dawson, J., Quinn, T.J., and Walters, M. (2007) Uric acid reduction: A new paradigm in the management of cardiovascular risk? Current Medicinal Chemistry, 14(17). pp. 1879-1886.

Finn, D., Dawson, J., Murray, L., Morton, R., Sloan, W., Walters, M., and McInnes, G. (2007) New-onset diabetes in hypertensive patients: an evaluation of the association with drug therapy and cardiovascular mortality. Journal of Human Hypertension, 21(10). pp. 842-843.

Quinn, T.J., Lees, K.R., Hardemark, H.G., Dawson, J., and Walters, M.R. (2007) Initial experience of a digital training resource for modified Rankin scale assessment in clinical trials. Stroke, 38(8). pp. 2257-2261. (doi:10.1161/STROKEAHA.106.480723)

Walker, T., McMahon, S., and Walters, M. (2007) Innovative orientation: a treasure hunt in Foundation Year one. Medical Education, 41(5). p. 514.

Bain, C., Lees, K., Lumsden, M., and Walters, M. (2006) Sex hormones and cerebral hemodynamics - Author's reply. Climacteric, 9(1). p. 67.

Dawson, J., and Walters, M. (2006) New and emerging treatments for stroke. British Medical Bulletin, 77-78. pp. 87-102. (doi:10.1093/bmb/ldl011)

Dawson, J., and Walters, M. (2006) Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease? British Journal of Clinical Pharmacology, 62. pp. 633-644. (doi:10.1111/j.1365-2125.2006.02785.x)

Dawson, J., Walters, M., and Lees, K. (2006) 21st century stroke - A medical emergency. Scottish Medical Journal, 51(3). pp. 34-41.

Milia, P., Muir, S., Alem, M., Lees, K., and Walters, M. (2006) Comparison of the effect of diuretics on carotid blood flow in stroke patients. Journal of Cardiovascular Pharmacology, 47. pp. 446-449.

Nazir, F., Alem, M., Small, M., Connell, J., Lees, K., Walters, M., and Cleland, S. (2006) Blunted response to systemic nitric oxide synthase inhibition in the cerebral circulation of patients with Type 2 diabetes. Diabetic Medicine, 23. pp. 398-402. (doi:10.1111/j.1464-5491.2005.01815.x)

Newman, E.J., Rahman, F.S., Lees, K.R., Weir, C.J., and Walters, M. (2006) Elevated serum urate concentration independently predicts poor outcome following stroke in patients with diabetes. Diabetes: Metabolism Research and Reviews, 22(1). pp. 79-82.

Walters, M., Weir, C., and Lees, K. (2006) A randomised, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischaemic stroke patients. Cerebrovascular Diseases, 22. pp. 116-122. (doi:10.1159/000093239)

Aslanyan, S., Weir, C., McInnes, G., Reid, J., Walters, M., and Lees, K. (2005) Statin administration prior to ischaemic stroke onset and survival: exploratory evidence from matched treatment-control study. European Journal of Neurology, 12. pp. 493-498.

Bain, C., Lees, K., Lumsden, M., and Walters, M. (2005) Effect of a gonadotropin releasing hormone analog on cerebral hemodynamics in premenopausal women. Climacteric, 8. pp. 193-197. (doi:10.1080/13697130500118068)

Dawson, J., and Walters, M. (2005) Development and validation of a stroke recognition tool. Lancet Neurology, 4(11). pp. 691-693.

Lees, K., and Walters, M. (2005) Acute stroke and diabetes. Cerebrovascular Diseases, 20(Suppl.). pp. 9-14. (doi:10.1159/000088232)

Walters, M., Kaste, M., Lees, K., Diener, H., Hommel, M., De Keyser, J., Steiner, H., and Versavel, M. (2005) The AMPA antagonist ZK 200775 in patients with acute ischaemic stroke: A double-blind, multicentre, placebo-controlled safety and tolerability study. Cerebrovascular Diseases, 20. pp. 304-309. (doi:10.1159/000087929)

Walters, M., Muir, K., Harbison, J., Lees, K., and Ford, G. (2005) Intravenous thrombolysis for acute ischaemic stroke: Preliminary experience with recombinant tissue plasminogen activator in the UK. Cerebrovascular Diseases, 20. pp. 438-442. (doi:10.1159/000088982)

Walters, M., Weir, C., Adams, F., and Lees, K. (2005) The prognostic significance of visible infarction on computed tomography following lacunar stroke: Results of a long-term follow-up study. Journal of Neuroimaging, 15. pp. 331-335. (doi:10.1177/1051228405279993)

Alem, M., Nazir, F., Walters, M., Elliott, H., Lees, K., Connell, J., and Cleland, S. (2004) Arterial stiffness in type 2 diabetes: Altered pattern of response to systemic NOS inhibition. Journal of Hypertension, 22. S194-S195.

Bain, C., Walters, M., Lees, K., and Lumsden, M. (2004) The effect of HRT on cerebral haemodynamics and cerebral vasomotor reactivity in post-menopausal women. Human Reproduction, 19. pp. 2411-2414. (doi:10.1093/humrep/deh396)

Muir, S., Shah, I., Walters, M., and Lees, K. (2004) Perindopril improves cerebral vasomotor reactivity in patients with lacunar infarction. Stroke, 35(1). p. 303.

Nazir, F., Alem, M., Walters, M., Cleland, S., and Lees, K. (2004) Cerebral nitric oxide - Mediated vasodilatation is impaired in diabetics. Stroke, 35(1). p. 306.

Walters, M., Muir, S., Shah, I., and Lees, K. (2004) Effect of perindopril on cerebral vasomotor reactivity in patients with lacunar infarction. Stroke, 35. pp. 1899-1902. (doi:10.1161/01.STR.0000131748.12553.ed)

Weir, C., Muir, S., Walters, M., and Lees, K. (2004) Yin and Yang of uric acid in patients with stroke - Response. Stroke, 35(1). E11-E12.

Dhanjal, T., Walters, M., and MacMillan, N. (2003) Claude's syndrome in association with posterior cerebral artery stenosis. Scottish Medical Journal, 48. pp. 91-92.

Shah, I., Walters, M., and McKillop, J. (2003) Interactive acute medicine. Medical Education, 37(11). pp. 1046-1047.

Walters, M., Shah, I., Van Acker, J., Carr, L., Weir, C., and Lees, K. (2003) Do transient ischaemic attacks attenuate severity of subsequent stroke? Stroke, 34(1). p. 320.

Weir, C., Muir, S., Walters, M., and Lees, K. (2003) Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke, 34. pp. 1951-1956. (doi:10.1161/01.STR.0000081983.34771.D2)

Weir, C., Sattar, N., Walters, M., and Lees, K. (2003) Low triglyceride, not low cholesterol concentration, independently predicts poor outcome following acute stroke. Cerebrovascular Diseases, 16. pp. 76-82. (doi:10.1159/000070119)

Walters, M., Bradford, A., Fischer, J., and Lees, K. (2002) Early clinical experience with the novel NMDA receptor antagonist CNS 5161. British Journal of Clinical Pharmacology, 53. pp. 305-311.

Walters, M., Bolster, A., Dyker, A., and Lees, K. (2001) Effect of perindopril on cerebral and renal perfusion in stroke patients with carotid disease. Stroke, 32. pp. 473-478.

Walters, M., Dyker, A., and Lees, K. (2000) The effect of perindopril on cerebral and renal perfusion in stroke patients with carotid disease. Journal of Hypertension, 18. S53-S53.

Walters, M., and Reid, J. (2000) Vasopeptidase inhibition: cardiovascular therapy for the new millennium? Journal of Human Hypertension, 14(9). pp. 537-539.

Walters, M., Bradford, A., and Lees, K. (1999) Early clinical experience with the novel NMDA antagonist CNS 5161. Stroke, 30(1). p. 264.

Walters, M., Foster, J., Cockburn, M., McMillan, N., and Lees, K. (1999) Imaging of acute ischaemic stroke by diffusion-weighted magnetic resonance at 1.0 tesla. Stroke, 30(1). p. 277.

Conference Proceedings

Kepli, W. M., Fulton, R. L., Walters, M., Ali, M., Bath, P. M., and Dawson, J. (2014) Antiplatelet therapy following ischemic stroke - continue or change pre-existing therapy? In: International Stroke Conference 2014, San Diego, CA, USA, 12-14 Feb 2014, A135.

This list was generated on Fri Feb 27 10:15:34 2015 GMT.